Literature DB >> 23116073

The CyberKnife radiosurgery system for lung cancer.

Joost Jan Nuyttens1, Marjan van de Pol.   

Abstract

The CyberKnife is a frameless image-guided radiotherapy system involving a 6-MV linear accelerator mounted on a robotic arm. The imaging system consists of two diagnostic x-ray sources mounted to the ceiling paired with amorphous silicon detectors to acquire live digital radiographic images of the tumor or tumor surrogates including bony anatomy or implanted fiducial markers. The Synchrony system enables 4D real-time tracking of tumors that move with respiration. Owing to this complex system, moving tumors can be treated with an accuracy of 2 mm or less while patients breathe normally. Clinical results of inoperable patients with peripheral early-stage lung cancer are excellent. The toxicity is low and the treatment does not result in a loss in quality of life.

Entities:  

Mesh:

Year:  2012        PMID: 23116073     DOI: 10.1586/erd.12.35

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  19 in total

1.  eComment. Is surgery still worthwhile as compared to stereotactic ablative radiotherapy or CyberKnife in high-risk surgical patients with Stage I non-small-cell-lung cancer?

Authors:  Paolo Scanagatta
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-11

2.  Clinical outcomes of cyberknife stereotactic radiosurgery for lung metastases.

Authors:  Zhen Wang; Qing-Tao Kong; Jing Li; Xin-Hu Wu; Bing Li; Ze-Tian Shen; Xi-Xu Zhu; Yong Song
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 3.  Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.

Authors:  Susanne Temming; Martin Kocher; Erich Stoelben; Lars Hagmeyer; De-Hua Chang; Konrad Frank; Khosro Hekmat; Juergen Wolf; Wolfgang W Baus; Robert Semrau; Christian Baues; S Marnitz
Journal:  Strahlenther Onkol       Date:  2017-08-15       Impact factor: 3.621

4.  Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma.

Authors:  Mauro Loi; Marloes Duijm; Sarah Baker; Linda Rossi; Dirk Grunhagen; Cornelis Verhoef; Joost Nuyttens
Journal:  Radiol Med       Date:  2018-06-19       Impact factor: 3.469

5.  High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study.

Authors:  Yasuhiro Ryuno; Takanori Abe; Misaki Iino; Satoshi Saito; Tomomi Aoshika; Tomohiro Oota; Mitsunobu Igari; Ryuta Hirai; Yu Kumazaki; Kyoichi Kaira; Hiroshi Kagamu; Hironori Ishida; Shin-Ei Noda; Shingo Kato
Journal:  Radiat Oncol       Date:  2022-07-19       Impact factor: 4.309

Review 6.  Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

Authors:  Percy Lee; Billy W Loo; Tithi Biswas; George X Ding; Issam M El Naqa; Andrew Jackson; Feng-Ming Kong; Tamara LaCouture; Moyed Miften; Timothy Solberg; Wolfgang A Tome; An Tai; Ellen Yorke; X Allen Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-05       Impact factor: 8.013

7.  Analysis of clinical efficacy of CyberKnife(®) treatment for locally advanced pancreatic cancer.

Authors:  Yongchun Song; Zhiyong Yuan; Fengtong Li; Yang Dong; Hongqing Zhuang; Jingsheng Wang; Huaming Chen; Ping Wang
Journal:  Onco Targets Ther       Date:  2015-06-12       Impact factor: 4.147

8.  Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer.

Authors:  Rutger J Ubels; Sahar Mokhles; Eleni R Andrinopoulou; Cornelia Braat; Noëlle C van der Voort van Zyp; Shafak Aluwini; Joachim G J V Aerts; Joost J Nuyttens
Journal:  Radiat Oncol       Date:  2015-04-22       Impact factor: 3.481

9.  Feasibility study of automated framework for estimating lung tumor locations for target-based patient positioning in stereotactic body radiotherapy.

Authors:  Satoshi Yoshidome; Hidetaka Arimura; Katsumasa Nakamura; Yoshiyuki Shioyama; Kazushige Atsumi; Yasuhiko Nakamura; Hideki Yoshikawa; Kei Nishikawa; Hideki Hirata
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

10.  Stereotactic radiosurgery, a potential alternative treatment for pulmonary metastases from osteosarcoma.

Authors:  Wenxi Yu; Lina Tang; Feng Lin; Dake Li; Jun Wang; Yao Yang; Zan Shen
Journal:  Int J Oncol       Date:  2014-02-10       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.